Amit Sachdev, EVP, Chief Patient Officer at VERTEX PHARMACEUTICALS INC / MA (VRTX), sold 7,294 shares at $228.89 ($1.7M) on 2020-02-03, disclosed to the SEC on 2020-02-05.
Seasonal sale ($1.7M) by EVP, Chief Patient Officer — this insider has traded VRTX in February in at least three consecutive prior years. Pattern-driven, low signal.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $228.89 | 500 | $114K | 6.8% |
| 2 | $230.07 | 714 | $164K | 9.7% |
| 3 | $230.07 | 714 | $164K | 9.7% |
| 4 | $231.25 | 1,306 | $302K | 17.9% |
| 5 | $231.25 | 1,306 | $302K | 17.9% |
| 6 | $231.92 | 1,177 |
| $273K |
| 16.2% |
| 7 | $231.92 | 1,177 | $273K | 16.2% |
| 8 | $232.87 | 400 | $93K | 5.5% |
| Total | $231.16 avg | 7,294 | $1.7M | 100% |
| Filing → |
| VRTX | SELL | 2024-05-17 | $14K | — | Filing → |
| VRTX | SELL | 2024-02-27 | $2.6M | — | Filing → |
| VRTX | SELL | 2024-02-23 | $2.7M | — | Filing → |